share_log

4 Psychedelics Companies Post Financial Results: Learn How Field Trip, Wesana, Braxia and Irwin Naturals Performed

4 Psychedelics Companies Post Financial Results: Learn How Field Trip, Wesana, Braxia and Irwin Naturals Performed

4家迷幻藥公司公佈財務業績:瞭解field Trip、Wesana、Braxia和Irwin Naturals的表現
Benzinga Real-time News ·  2022/08/30 15:48
Field Trip (NASDAQ:FTRP), Wesana (OTCQB:WSNAF), Braxia (OTC:BRAXF) and Irwin Naturals (OTC: IWINF) released their quarterly results.
實地考察(納斯達克:FTRP), 韋薩納(場外交易代碼:WSNAF)、布拉夏(場外交易代碼:BRAXF)和歐文自然(場外交易代碼:IWINF)公佈了季度業績。
Field Trip Health & Wellness Ltd.
田野旅行健康健康有限公司。
Psychedelic-assisted therapy provider Field Trip (TSXV:FTHW) reported its fiscal and business results for the three-month period ended June 30, 2022.
迷幻輔助治療提供者實地考察旅行(多倫多證券交易所股票代碼:FTHW)公佈了截至2022年6月30日的三個月的財務和業務業績。
The company recently split into two new public companies to separate drug development on one hand, and healthcare and wellness on the other: Field Trip Discovery and Field Trip Health, which are now called Reunion Neuroscience Inc. and Field Trip Health & Wellness (or Field Trip alone).
該公司最近拆分成兩家新的上市公司,一方面分離藥物開發,另一方面分離醫療保健和健康:實地考察發現和實地考察健康,這兩家公司現在名為留尼汪神經科學公司和實地旅行健康與健康(或單獨實地旅行)。
The latter's financial results for the...
後者的財務業績...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論